PI3King the Environment for Growth: PI3K Activation Drives Transcriptome Changes That Support Oncogenic Growth

PI3K signaling plays an integral role in cells, coordinating the necessary alterations in cellular metabolism and programs to support survival and proliferation. In the first genome-wide analysis of alternative splicing in PIK3CA-mutant breast cancer, Ladewig and colleagues show that activating muta...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer research (Chicago, Ill.) Ill.), 2022-06, Vol.82 (12), p.2216-2218
Hauptverfasser: Claridge, Sally E, Hopkins, Benjamin D
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2218
container_issue 12
container_start_page 2216
container_title Cancer research (Chicago, Ill.)
container_volume 82
creator Claridge, Sally E
Hopkins, Benjamin D
description PI3K signaling plays an integral role in cells, coordinating the necessary alterations in cellular metabolism and programs to support survival and proliferation. In the first genome-wide analysis of alternative splicing in PIK3CA-mutant breast cancer, Ladewig and colleagues show that activating mutations in PIK3CA alter the use of known exons and splice junctions, leading to changes in gene expression and transcription factor activity that promote an oncogenic phenotype. Their work reveals a novel mechanism underlying the functional impact of PI3K signal activation in the context of breast cancer, where PIK3CA mutations are common and PI3K inhibitors are part of the standard of care. Their studies uncover a feedforward mechanism by which PI3K signaling enables a shift in the spectrum of translated splice variants as another method through which the PI3K pathway has evolved to regulate its own activity, thereby modifying the cellular response to upstream activation based on the signaling that has come before. These findings have profound implications for understanding the evolution of the PI3K pathway and the rewiring of cells in response to prolonged or repeated signal activation. See related article by Ladewig et al., p. 2269.
doi_str_mv 10.1158/0008-5472.CAN-22-1466
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10309115</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2676922275</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3276-ea583c44b2276915890dc1a3bba3f93b4106b90091f1ee9ac1b16858d5ff9de43</originalsourceid><addsrcrecordid>eNpVkV9PwyAUxYnR6Jx-BA2PvnTyp3StL2apcxoXNVGfCWV0xaxQgc347aVxLvpELpx77rn8ADjDaIQxyy8RQnnC0jEZlZPHhJAEp1m2BwaY0TwZpynbB4Od5ggce_8eS4YROwRHlI0RyQs8AOb5nj5os4ShUXBqNtpZ0yoTYG0dnDn7GZor2GvgRAa9EUFbA2-c3igPX50wXjrdBdsqWDbCLPvbRgT4su466wJ8MtIuldFy63UCDmqx8up0ew7B2-30tbxL5k-z-3IyTyQl4yxRguVUpmlFYlXEdQu0kFjQqhK0LmiVYpRVBUIFrrFShZC4wlnO8gWr62KhUjoE1z--3bpq1ULGjZxY8c7pVrgvboXm_1-MbvjSbjhGNLrGTxyCi62Dsx9r5QNvtZdqtRJG2bXnJIvJSMzXS9mPVDrrvVP1bg5GvIfFexC8B8EjLE4I72HFvvO_IXddv3ToNzigkXM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2676922275</pqid></control><display><type>article</type><title>PI3King the Environment for Growth: PI3K Activation Drives Transcriptome Changes That Support Oncogenic Growth</title><source>MEDLINE</source><source>American Association for Cancer Research</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Claridge, Sally E ; Hopkins, Benjamin D</creator><creatorcontrib>Claridge, Sally E ; Hopkins, Benjamin D</creatorcontrib><description>PI3K signaling plays an integral role in cells, coordinating the necessary alterations in cellular metabolism and programs to support survival and proliferation. In the first genome-wide analysis of alternative splicing in PIK3CA-mutant breast cancer, Ladewig and colleagues show that activating mutations in PIK3CA alter the use of known exons and splice junctions, leading to changes in gene expression and transcription factor activity that promote an oncogenic phenotype. Their work reveals a novel mechanism underlying the functional impact of PI3K signal activation in the context of breast cancer, where PIK3CA mutations are common and PI3K inhibitors are part of the standard of care. Their studies uncover a feedforward mechanism by which PI3K signaling enables a shift in the spectrum of translated splice variants as another method through which the PI3K pathway has evolved to regulate its own activity, thereby modifying the cellular response to upstream activation based on the signaling that has come before. These findings have profound implications for understanding the evolution of the PI3K pathway and the rewiring of cells in response to prolonged or repeated signal activation. See related article by Ladewig et al., p. 2269.</description><identifier>ISSN: 0008-5472</identifier><identifier>ISSN: 1538-7445</identifier><identifier>EISSN: 1538-7445</identifier><identifier>DOI: 10.1158/0008-5472.CAN-22-1466</identifier><identifier>PMID: 35702891</identifier><language>eng</language><publisher>United States</publisher><subject>Breast Neoplasms - genetics ; Breast Neoplasms - metabolism ; Cell Line, Tumor ; Class I Phosphatidylinositol 3-Kinases - antagonists &amp; inhibitors ; Female ; Humans ; Mutation ; Phosphatidylinositol 3-Kinases - genetics ; Phosphatidylinositol 3-Kinases - metabolism ; RNA Splicing ; Transcriptome</subject><ispartof>Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12), p.2216-2218</ispartof><rights>2022 American Association for Cancer Research.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3276-ea583c44b2276915890dc1a3bba3f93b4106b90091f1ee9ac1b16858d5ff9de43</citedby><cites>FETCH-LOGICAL-c3276-ea583c44b2276915890dc1a3bba3f93b4106b90091f1ee9ac1b16858d5ff9de43</cites><orcidid>0000-0002-2539-0178</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,3356,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35702891$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Claridge, Sally E</creatorcontrib><creatorcontrib>Hopkins, Benjamin D</creatorcontrib><title>PI3King the Environment for Growth: PI3K Activation Drives Transcriptome Changes That Support Oncogenic Growth</title><title>Cancer research (Chicago, Ill.)</title><addtitle>Cancer Res</addtitle><description>PI3K signaling plays an integral role in cells, coordinating the necessary alterations in cellular metabolism and programs to support survival and proliferation. In the first genome-wide analysis of alternative splicing in PIK3CA-mutant breast cancer, Ladewig and colleagues show that activating mutations in PIK3CA alter the use of known exons and splice junctions, leading to changes in gene expression and transcription factor activity that promote an oncogenic phenotype. Their work reveals a novel mechanism underlying the functional impact of PI3K signal activation in the context of breast cancer, where PIK3CA mutations are common and PI3K inhibitors are part of the standard of care. Their studies uncover a feedforward mechanism by which PI3K signaling enables a shift in the spectrum of translated splice variants as another method through which the PI3K pathway has evolved to regulate its own activity, thereby modifying the cellular response to upstream activation based on the signaling that has come before. These findings have profound implications for understanding the evolution of the PI3K pathway and the rewiring of cells in response to prolonged or repeated signal activation. See related article by Ladewig et al., p. 2269.</description><subject>Breast Neoplasms - genetics</subject><subject>Breast Neoplasms - metabolism</subject><subject>Cell Line, Tumor</subject><subject>Class I Phosphatidylinositol 3-Kinases - antagonists &amp; inhibitors</subject><subject>Female</subject><subject>Humans</subject><subject>Mutation</subject><subject>Phosphatidylinositol 3-Kinases - genetics</subject><subject>Phosphatidylinositol 3-Kinases - metabolism</subject><subject>RNA Splicing</subject><subject>Transcriptome</subject><issn>0008-5472</issn><issn>1538-7445</issn><issn>1538-7445</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkV9PwyAUxYnR6Jx-BA2PvnTyp3StL2apcxoXNVGfCWV0xaxQgc347aVxLvpELpx77rn8ADjDaIQxyy8RQnnC0jEZlZPHhJAEp1m2BwaY0TwZpynbB4Od5ggce_8eS4YROwRHlI0RyQs8AOb5nj5os4ShUXBqNtpZ0yoTYG0dnDn7GZor2GvgRAa9EUFbA2-c3igPX50wXjrdBdsqWDbCLPvbRgT4su466wJ8MtIuldFy63UCDmqx8up0ew7B2-30tbxL5k-z-3IyTyQl4yxRguVUpmlFYlXEdQu0kFjQqhK0LmiVYpRVBUIFrrFShZC4wlnO8gWr62KhUjoE1z--3bpq1ULGjZxY8c7pVrgvboXm_1-MbvjSbjhGNLrGTxyCi62Dsx9r5QNvtZdqtRJG2bXnJIvJSMzXS9mPVDrrvVP1bg5GvIfFexC8B8EjLE4I72HFvvO_IXddv3ToNzigkXM</recordid><startdate>20220615</startdate><enddate>20220615</enddate><creator>Claridge, Sally E</creator><creator>Hopkins, Benjamin D</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-2539-0178</orcidid></search><sort><creationdate>20220615</creationdate><title>PI3King the Environment for Growth: PI3K Activation Drives Transcriptome Changes That Support Oncogenic Growth</title><author>Claridge, Sally E ; Hopkins, Benjamin D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3276-ea583c44b2276915890dc1a3bba3f93b4106b90091f1ee9ac1b16858d5ff9de43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Breast Neoplasms - genetics</topic><topic>Breast Neoplasms - metabolism</topic><topic>Cell Line, Tumor</topic><topic>Class I Phosphatidylinositol 3-Kinases - antagonists &amp; inhibitors</topic><topic>Female</topic><topic>Humans</topic><topic>Mutation</topic><topic>Phosphatidylinositol 3-Kinases - genetics</topic><topic>Phosphatidylinositol 3-Kinases - metabolism</topic><topic>RNA Splicing</topic><topic>Transcriptome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Claridge, Sally E</creatorcontrib><creatorcontrib>Hopkins, Benjamin D</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancer research (Chicago, Ill.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Claridge, Sally E</au><au>Hopkins, Benjamin D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>PI3King the Environment for Growth: PI3K Activation Drives Transcriptome Changes That Support Oncogenic Growth</atitle><jtitle>Cancer research (Chicago, Ill.)</jtitle><addtitle>Cancer Res</addtitle><date>2022-06-15</date><risdate>2022</risdate><volume>82</volume><issue>12</issue><spage>2216</spage><epage>2218</epage><pages>2216-2218</pages><issn>0008-5472</issn><issn>1538-7445</issn><eissn>1538-7445</eissn><abstract>PI3K signaling plays an integral role in cells, coordinating the necessary alterations in cellular metabolism and programs to support survival and proliferation. In the first genome-wide analysis of alternative splicing in PIK3CA-mutant breast cancer, Ladewig and colleagues show that activating mutations in PIK3CA alter the use of known exons and splice junctions, leading to changes in gene expression and transcription factor activity that promote an oncogenic phenotype. Their work reveals a novel mechanism underlying the functional impact of PI3K signal activation in the context of breast cancer, where PIK3CA mutations are common and PI3K inhibitors are part of the standard of care. Their studies uncover a feedforward mechanism by which PI3K signaling enables a shift in the spectrum of translated splice variants as another method through which the PI3K pathway has evolved to regulate its own activity, thereby modifying the cellular response to upstream activation based on the signaling that has come before. These findings have profound implications for understanding the evolution of the PI3K pathway and the rewiring of cells in response to prolonged or repeated signal activation. See related article by Ladewig et al., p. 2269.</abstract><cop>United States</cop><pmid>35702891</pmid><doi>10.1158/0008-5472.CAN-22-1466</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0002-2539-0178</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0008-5472
ispartof Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12), p.2216-2218
issn 0008-5472
1538-7445
1538-7445
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10309115
source MEDLINE; American Association for Cancer Research; EZB-FREE-00999 freely available EZB journals
subjects Breast Neoplasms - genetics
Breast Neoplasms - metabolism
Cell Line, Tumor
Class I Phosphatidylinositol 3-Kinases - antagonists & inhibitors
Female
Humans
Mutation
Phosphatidylinositol 3-Kinases - genetics
Phosphatidylinositol 3-Kinases - metabolism
RNA Splicing
Transcriptome
title PI3King the Environment for Growth: PI3K Activation Drives Transcriptome Changes That Support Oncogenic Growth
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T16%3A10%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=PI3King%20the%20Environment%20for%20Growth:%20PI3K%20Activation%20Drives%20Transcriptome%20Changes%20That%20Support%20Oncogenic%20Growth&rft.jtitle=Cancer%20research%20(Chicago,%20Ill.)&rft.au=Claridge,%20Sally%20E&rft.date=2022-06-15&rft.volume=82&rft.issue=12&rft.spage=2216&rft.epage=2218&rft.pages=2216-2218&rft.issn=0008-5472&rft.eissn=1538-7445&rft_id=info:doi/10.1158/0008-5472.CAN-22-1466&rft_dat=%3Cproquest_pubme%3E2676922275%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2676922275&rft_id=info:pmid/35702891&rfr_iscdi=true